Document is current
Any future updates will be listed below
-
Authors
Papadopoulos, Nikolaos G.
Zuberbier, Torsten
-
Funding
Funding for this research was provided by:
Menarini Group
- License Information
-
More Information
Article History
Received: 3 June 2019
Accepted: 4 October 2019
First Online: 23 October 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Dr. Papadopoulos reports Grants from Gerolymatos International SA and Capricare; personal fees from Hal, Novartis, Menarini/Faes Farma, Mylan/Meda, Nutricia, Sanofi, Biomay, AstraZeneca, GSK, MSD and Asit Biothech, outside the submitted work.Dr. Zuberbier reports grants or honoraria from AstraZeneca, AbbVie, ALK, Almirall, Astellas, Bayer Health Care, Bencard, Berlin Chemie, FAES, HAL, Henkel, Kryolan, Leti, L’Oreal, Meda, Menarini, Merck, MSD, Novartis, Pfizer, Sanofi, Stallergenes, Takeda, Teva, UCB. He also reports the following organizational affiliations: Committee member, WHO-Initiative “Allergic Rhinitis and its Impact on Asthma” (ARIA). Member of the Board, German Society for Allergy and Clinical Immunology (DGAKI). Head, European Centre for Allergy Research Foundation (ECARF). Secretary General, Global Allergy and Asthma European Network (GA<sup>2</sup>LEN). Member, Committee on Allergy Diagnosis and Molecular Allergology, World Allergy Organization (WAO).”
